Our evaluation of the effects of SGLT2 inhibition on the viability, colony formation, and migration of VHL mutant ccRCC cells revealed that the SGLT2i dapagliflozin inhibited progression of ccRCC partly due to the induction of apoptosis. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.